COMMENT

Biotech and China: a global opportunity

Intranasal ketamine could effectively treat phantom pain

insight

Tides are turning for EU biosimilars

The EU biosimilar approval wave appears to have peaked in 2018 and is now experiencing a decline

insight

Tides are turning for EU biosimilars

The EU biosimilar approval wave appears to have peaked in 2018 and is now experiencing a decline

insight

Europe reports the highest prevalence of chronic cough

comment

Could vaccine hesitancy impact hearing disorders?

Biotech and China: a global opportunity

Intranasal ketamine could effectively treat phantom pain

02/24/2024 14:38:20

09/23/2021 00:00:00

Go to article: Home | Unpacking innovation in biologics Go to article: In this issue Go to article: Contents Go to article: Myonex Go to article: Controlant Company Insight Go to article: Controlant Go to article: SHL Medical Go to article: Labcorp Go to article: Reuters Go to article: Briefing Go to article: Industry news Go to article: The pharma industry briefing Go to article: Covid-19 executive briefing by GlobalData Go to article: Mimotopes Company Insight Go to article: Mimotopes Go to article: TQS Integration Company Insight Go to article: TQS Intergration Go to article: Biesterfeld Go to article: Comment Go to article: Biotech and China: a global opportunity Go to article: Intranasal ketamine could effectively treat phantom pain Go to article: EU biosimilar wave slows as biosimilar approvals decrease in the EU Go to article: Biosynth Carbosynth Company Insight Go to article: Biosynth Carbosynth Go to article: Molnár-Institute Company Insight Go to article: Molnar-Institute Go to article: Skyepharma Go to article: In Depth Go to article: Unpacking the complex challenge of biologics Go to article: Living medicines: using bacteria to fight cancer Go to article: The marred history of HIV vaccine trials Go to article: Has Covid-19 exposed the weakness of the US pharma supply chain?Go to article: How the pandemic pushed pharmacovigilance to innovate Go to article: ExeVir: the llama-derived antibody that could fight Covid-19 Go to article: BEA Technologies Go to article: Watlow Go to article: Duoject Go to article: Butterworth Go to article: In Data Go to article: Data: Big Data hiring efforts in pharma Go to article: The pharma industry key list Go to article: Global markets and indices Go to article: Macro-economic indicators Go to article: Macro-economic indicators (page 2)Go to article: Events Go to article: Next issue